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The potential to reduce cost was the major motivating factor 
for many centers in Europe, South America, Asia and Cana:‘a 
to reuse percutaneous transhrminal coronary angiopksty cath- 
eters In Canada, a survey was conducted among all of the 46 
centers that provide cardiac cathetetition. Of the 44 centers 
that responded, 3% of hospitals reuse cardiac catheters (1). 
Using data from two hospitals in Montreal, the Council for 
Health Techaologies in Quebec (2) estimated that when a 
balloon catheter was reused two times, the estimated savings 
was $750 per procednre. 
In 1994, -420,OOtl coronary angioplasty procedures were 
performed in the United States (3). At an average charge of 
$16,000 per procedure (4). the initial hospitalization charges 
amounted to more than $6 billion. Although much of the 
etptipat used for coronary angioplasty is expensive, under 
direction of the Food and Drug Admit&ration, coronary 
angiaplasty equipment is labeled “for single use *; there- 
fo:e, reuse is not currently practiced ir, the United States. At 
The %est case* sceoario olked a potential savings of$4t?@ (5.5% 
of total in-hospital cwst), whereas the %orst case* wnario 
resulted la an increased cwt of $1#75 (12.2% of total in-hospital 
cat) compared wltb the single-w strategy. Cost of the %kely 
case”sceoahwassimilartotbatofthesingle-oses&a~. 
Sensii anatyses i&Wed the ditfefent rates of rem - - 
tionaadcostoftlallooacathetelsrequlredtoolFsetpotential 
rmvingsineachstrategy. 
Cd. Altlloagh mlslng cmmlaJy an@oplasty catkters 
may reduce total in-hospital cost& even a modest increase in 
eo~ti0n.q req&lug mqjent rewsc&btion may o&t any 
potenttal savlags. Ekrcpnrr, if all increase la complk&lons and 
fKOCEdlUOtilllOCMkavoided,thereil%strategplUJSSlgld6~Dt 
CT.0llOlldCpoteetkdM~nltinlatefy.lMybOXtMd~tOotber 
jmstaneous coronary ioterventlom3l equipment. 
(JAI0 cdl c47niid 1996;28:106-11) 
the Cleveland Clinic, potentially reusable coronary angioplasty 
equipment was estimated to comprise -18% of the total cost 
(5). If coronary angioplasty equipment could be reused, the 
total cost could potentially be reduced by more than $1 billion 
per year in the United States. 
Recently, in the only publi&d prospective study on the 
topic, Plante et al. (6) compared the experience of a Quebec 
hospital that reused catheters with that of a single-use center in 
Toronto. Procedural success rates were similar in both centers 
(88%) Over the IO-month study period, the estimated savings 
was $258 per patient in the reuse center. However, these 
estimated savings might have been offset by the higher amount 
of contrast agent and the greater number of balloon catheters 
used, as well as by the increased complication rates, which 
resulted in a greater need for urgent revascularization (Table 
1). To explore the potential cost savings of various strategies of 
coronary angioplasty catheter reuse, we devised three theoret- 
ical cost models based on the findings of the study by Plante et 
al. (6) and actual coronary angicplasty costs at the Cleveland 
anii. 
. TBoorehralmudekandassntuRtions.-fhreemodekof ---. 
Dr.EtieJ.TopdDepMmKatdCsdidogy, reuse,designatedas~~ose,““bestcase”aad”like~Jrease” 
DdF2S,!JWEWJidAAveocre,~OJOO44195. scenarios (Table 2), were ankbu&dwitbtheactualcostsof 
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Tahle 1. procedural Results and Adverse Events From Coronary 
Angioplasty Performed Wii New (single-use center) or Reused 
&se center) Catheters* 
Single-Use Center Reuse Center 
(n = 373) (n = 320) p value 
43% 275% 
57% 70% 
0.3% 25% 
26% 3.7% 
0.7% 3.0% 
3.3% 6.7% 
1.2 13 
1.2 2.4 
165 201 
68 81 
1.6% 3.1% 
1.1% 4.1% 
0.8% 15% 
0.8% 19% 
NS 
<. G.!ms 
NS 
NS 
< 0.01 
< 0.025 
< 0.02 
< o.ooal1 
-= O.oool 
< 0.ooo1 
NS 
< o.o2s 
NS 
NS 
*Adapted from Ptaate et al. (6). Data pressted are aumber m percent of 
patiL3it%unlesscrthCrwiseindicatedCAElG=COroOary~bypassgran 
surgeq; Cath lab = eatheterivtioa t&oratory. 
mromy angioplasty at the Cleveland Clinic (where only new 
catheters are used) and from &ii data from the study by 
Plante et al. (6) (Table 1). The mst in these models was 
calculated for different numbers of balloons and different rates 
of urgent revascularization. Patients experiencing abrupt vessel 
&sure outside the cardiac catheterization laboratory were 
assumed to return to the laboratory for urgent coronary 
angiopIasty. Guide wires wete assumed not to be reusable 
because they are fragile arid needed to be shaped for each 
lesion. As the number of guiding catheters used in both 
Canadian centers was approsimately the same, and because of 
the mst was relatively low ($70 to $!90), they were not 
considered as a separate mst item. Although the amount of 
mntrast agent used was significantly higher in the reuse center 
compared with the single-use center, the mst difference was 
small ($15) in relation to the total mst of the procedure 
Table 2. Variabks Used for Estimated Gut Deterur~aatioa for 
Three Theoretical Models of Catheter Reuse 
No. of hall- 1.2 24 1.2 1.8 
No.oftimesrewabk NA 2 5 s 
--(w WA al 100 80 
-clpea4atieotw 165 201 all 201 
oat&~ downe (St) a1 3.0 0.7 1.0 
urk”t cJ4BG w 1.1 4.1 1.1 2.6 
CABG=axomyarteqbypasgsh~NA=notap+abk. 
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(S,!JfM); therefore, we assumed that a similar amount of 
contrast agent was used in all the three scenarios. 
‘WcM Case”Scenatio. The rates for urgent coronary angjo- 
plasty and coronary artery bypass graft surgery and the number 
of balloon catheters used were assumed to be similar to those 
remrded For the reuse center r.hle 1). Only 80% of the 
balloons were assutned to be reusable, because after each use, 
changes in shape and profile could adversely affect perfor- 
mance. Balloon catheters were as!.umed to be reused twice 
based on data from the Council of Health Technologies in 
Quebec (2) showing that the largest incremental savings were 
achieved after two reuses. 
“Besl case” scenario. In this scenario, the rates for urgent 
coronary angioplasty and urgent bypass surgery and the num- 
ber of balloon catheters used were assumed to be similar to 
those reported for the single-use center (Table 1). AU balloons 
were asswned to be reusable, which is mnsistent with the 
estimate provided by the Council of Health Technoiogks in 
Quebec (2). In the study by Piante et al. (6), baboon catheters 
were reused an average of 5.4 times; therefore, in this scenario 
tive reuses were assumed. 
“Likes cast” SC&. This scenario was mnstructed in an 
attempt to ilbtstrate the likely scenario associated with catheter 
reusebecauseofthedifferencesinchnicalsettinganddRation 
strategies between the two centers (6). Rates for urgent 
coronary angioplasty and urgent bypass surgery and the num- 
ber of balloon catheters used were assumed to be the average 
of those of the single-use and the reuse center (Table 1). It is 
likely that not ah bafloon catheters muid be reused, therefore, 
&I% were assumed to be reusable. 
Cmwnary s8gioplstg. From June to Cktober 1994, at the 
Cleveland Clinic Foundation, a total of 1,516 balloon catheters 
were used at a total mst of $781373. The average mst of each 
catheter was $515. Over the same pet&r& 60% of the contrast 
agent used for mronaty angioph&y was ionic and 40% was 
nonionic. At a cost of $0.03 per miifihter of ionic mntrast agent 
and $1 per miflihter of nonionk mntmst agent, the average 
mst for each miUiliter of mntrast agent used was Eo.42. The, 
mst for rester&zing and repackagjng each catheter was esti- 
mated to be $20 (6). 
Duringthesameperiod,477baUoonangiophistyproee- 
dures were perfortned. Costs were determined by the Transi- 
tion System Incorporated hospital acmunting program, which 
cakulatedfisedandvariabfemstsofmsounesmnsumed 
inchding prof&onai and hospital setvices, using a bottom-up 
approach ($7). Professional m&were based on actual salarks 
and benefiti of -fT and indirect msts such as overhead and 
insumnm. Disposllble supplies, nonphysjcian iabor and indi- 
Rxtmslsaladetptllehaspitaloostslllescquisitioncosta 
were used for dkposabie supphes. IUonphyskian labor, such as 
nursing and secretarial sakes as wefi as benet?& were 
obtaheddiifromthesalatyseheduleandapportioned 
55% variable (based on the duration of time spent in the 
Qtheterizatioakbomtoryandilltensivecareunitalldon 
regular nwsing Boots) and 45% fkerf per promdure. fndirti 
hospital oosts, iocEnding major capital deprecistion and over- 
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head, were allocated based on factors such as patient volume 
and square footage. The median cost was Sg$OO with a 
standard deviatioo of $11,031. We used the cost difference 
between ekctive coronary angioplasty and eiedive with subse- 
quent urgent coronary ang&lasty to compute the additional 
ro%t for urgent coronary angioplasty. Of the patients undergo- 
ing elective with subsequent urgent coronary angioplasty, the 
median cost was 522,657. Therefore, the cost of an urgent 
coronary angioplasty procedure was assumed to be $13,857. 
Similarly, the cost diIIerence between elective coronary angio- 
pIasty and elective coronary angiophtsty with subsequent ur- 
gent bypass urgery was used to compute the additional cost 
for urgent bypass urgery. Of the patients undergoing elective 
coro,uuy angioplasty requiring subsequent urgent bypass ur- 
gery, the median cost was $36,167. As such, the cost of an 
urgent coronary angioplasty procedure was assumed to be 
S27367. 
SensItIvity analgsis. Sensitivity analyses were performed 
on the three models based on different rates of urgent revas- 
tadarimtion. To express the rates of urgent coronary angio- 
phty and bypass urgery as a single rate of revascuIarixation, 
an index-“unit of revascuk&ation”-was used. This unit was 
based on tbe rates for urgent coronary angioplasty (4.1%) and 
bypass urgery (3%) in the reuse center of the study by Plante 
et al. (6) (Table 1). Hence, the proportions or revascularixation 
procedures made. up by coronary aogioplasty and bypass 
surgery were 42% (3.On.l) and 58% (4.1/7.1), respectively. 
These proportions were similar in the single-use catheter. The 
cost of each “unit of revascularixation” was then computed as 
the sum of 42% of the ast of an urgent coronary angioplasty 
procedure and 58% of the cost of urgent bypass urgery. Using 
the amespondii costs at the Cleveland Clinic, each “unit of 
mtion” was $217 per patient. This index simplified 
presentation of the cost analysb and rates of revascularization. 
In addition to the rates of revascularixation, the cost of 
balkm catheters was used to determine in-hospital cost. 
Sensitivity analyses were also performed on the three models 
based on d&rent costs of balloon catheters. In each model, 
tbe difference between the reuse and single-use strategy was 
cahhted with the cost of balloon catheters ranging from $200 
to $700, which was the approximate range of costs for ,a balioon 
catheter at the Cleveland Clinic. A positive value was the 
amount associated with increased cost from the reuse strategy, 
and a negative vaIue was the amount associated with potential 
savings from the reuse strategy. 
Results 
0veraII In&ospItaI e&s. We found that in-hospital costs 
varied substantially with each, reuse strategy. Reuse of coro- 
nary augioplasty catheters may be associated with a potential 
savings of $Qso (5.5%) or an increased cost of $1,075 (12.2%) 
of the total idospital cost for each patient (Table 3). Etecause 
the primary consideration was the c~st-ehcy of reuse of 
~~themaximalpomibIesavingswasthecostofnew 
cAtheM& representing $618 per patient. The maximal poten- 
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Table 3. Cost Anat@ Per Patient for Three Models of Catheter 
Reuse for Coronary Angioplasty 
Sin&Use WorstCase BestCase LikelvC-w 
Bailoon c&ten (S) 618 538 123 279 
cmltr,:: ‘pu ($) 69 84 84 84 
urgent P-I-CA (3 ?7 416 97 138 
Urgent CABG (E) 301 1,122 301 712 
other casts (S) 7,715 7,715 7,715 7,712 
Total ($1 8,WJ 9,875 W3 8,929 
c4BG = cornnary anay bps graft surgery; FTCA = pcrcinan- 
translumiaat coronary angioP@y. 
tial savings in our models was ,$480, which was 78% of the cost 
of new catheters. In contrast, if the number of catheters used 
and rates of revascularization were significantly higher than 
those- in the single-use strategy, reuse may be associated with 
costs greater than 70% of the cost of new catheters. 
The relative costs of balloon catheters and urgent revascu- 
larixation procedures varied markedly among the different 
strategies. In the single-use strategy, catheters comprised 7% 
([$618/$8,800] X 100%) of the total in-hospital cost. On the 
other hand, based on our models, the cost of reusing catheters, 
including resterilixation, accounted for 1.5% ([$123/$8,320] X 
100%) to 5.4% (($538/$9,875] X 100%) of the respective total 
m-hospital cost (Table 3). The cost for urgent revascularixation 
was 3.5% for the single-use strategy, whereas the cost of urgent 
revascularixation ranged from 4.8% to 15.6% of the respective 
total in-hospital costs in reuse strategies. As the cost of 
revascularization was much higher than the cost of catheters, it
was not unexpected that the rates for urgent revascularixation 
were the principal determining factor for the diiIerences in cost 
among diierent reuse strategies. 
Seositlvlty analysis. Sensitivity analysis howed that poten- 
tial savings could be lost if the rates of revascularixation were 
only 2 to 4 “units,” depending on the reuse strategy (Fig. 1). 
The “worst case.” scenario allowed for the lowest rates of 
urgent revascularixation (i.e., 2 “units of revascularixation”). 
Therefore, for this scenario to afford any potential savings, the 
rates of urgent coronary angioplasty and urgent bypass urgery 
should not exceed 1.1% and 1.2%, respectively. 
The “likely case” scenario was constructed to project the 
most probable outcome associated with reuse of coronary 
angioplasty equipment. In the single-use strategy, there were 
1.8 “units of revascuh&ation,‘~ compared witb 3.3 in the 
“likely case” scenario. Therefore, to offset the potential for 
savings, the rates of revasslrrization wou!d need to be almost 
doubted. 
Sensitivity analysis based on the cost of tbe catheters 
showed that the potential for savings was more likely when the 
catheter cost was higher (Fig 2). However, this was related to 
the expense of urgent mvascularixation. When tbe rate of 
revascub&ation is low (as in the “best case” scenario), the 
catheter cost that results in potentiaI savings i  reduced. In the 
“IikeIy case” scenario, the cat of baIIoon catheters needed to 
be ahnost $700 for the totaI cost to equal the singIe-use 
strategy. 
.1.4X lb!,!. 3, XG. i 
Jdy 199630641 
01 . ,’ , ’ ,’ , , , 
0 1 2 3 I 6 a 7 
‘LblasotR 
Fv 1. Sensitivity a~aiy~is of the three theoretical models of cath- 
eterreusebasedontheratesof~entrevaseularization,showingthe 
relation between the total in-hasp&al 0x3 f0r.a patient undergoing 
ballnon angioplasty and the “units of revascularuatioo.” The heriz~~ 
tal line at $8&M marks the in-hospital cost with new balloon catheters. 
Amounts above this line we increased costs, and amounts below this 
linearepotential~Tbe~~indicatetheoumberof 
“units of revasadarization” needed to offset any potential savings 
cmpared with the single-use suategy. F&h “unit of revaxularizatioa” 
is a computed sum of 0.42 of an uqent percutaneous transluminal 
coronary angioplasty proahre and 0.58 of the cost of urgent coronary 
artery bypass graft surgery (see text for details). 
Discu~~sion 
Although experimental and clinical data suggest that cath- 
eter reuse may not be associated with an increased risk of 
morbidity and mortality to patients, including tbe rkks of 
equipment breakage (8), particulate body embolizatioo (8,9), 
infection (6,10-14), endotoxic reaction (15) and toxicity (16), 
the cost-benefits of catheter reuse strategies have not yet been 
closely evalyated. It has bee0 assumed that retIs would be 
associated with substantial cost savings (2,6,17). Our study was 
designed to determine the potential for cost savings in the 
thcorcticai catheter reuse models. Our modeling was instroc- 
tive in that if catheter reuse is associated with an even modest 
increase in ciinical complications, any potential savings would 
be lost. 
Although the Council for Health Technologies in Quebec 
(2) estimated savings of $l,UMJ (Canadian) per procedure, thk 
savings was calculated based only on the cost of balloon 
catheters and resterilhatioo and the omnber of Limes the 
catheter was reused. In that model all catheters were armed 
to be reusable. The possible ditferences in performance sod 
outcome associated with reused catheters were not considered. 
Our study examined the factors ad found that the rates of 
rev-0 were qcial in determinhg potential savings 
in a reose strategy. 
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Fw 2. Sensitivity anatysi of the three theoretical models of cath- 
eter reuse bared on the CDSI of balloon catheters, showing the 
ditierence in total in-ho@31 cost for a patient undergoing balloon 
angioplasty for each of the :c*ze strat+es and the single-use strategy 
using diierent a&s of b&on catheters. Negative values indicate the 
amount of potential savin& positive values indicate the amount of 
increased cost. 
IO a detailed cost anaiysii of percutane-ous coronary re.vascu- 
larizatioo, urgent bypass surgfq was estimated to increase cost 
by 37% (5). Tberefore, potential savings in a reuse strategy 
depended largely on the rates of urgent revascularizatron. Of
note was that the rate of adverse veots between the singie-use 
and reuse centers was similar (2.5% and l.l%, respectively) in
the subgroup of patients with stable angina. Ahbougb this 
tiding suggeds that reuse is more likeb to be cost-effective for 
these patieo~ a much larger number of patients is oeeded for 
con6rmation. 
Prevhsstu&s.Therea~~fortbebigherrateofcom- 
plications in the stody of Plante et aL, which resulted in 
heasedratesofnxscuhhthinthereueceoter,may 
have been &et the pmporth of patients with acute coromuy 
sy&omeswas3O%higber(6).DatafromtbeNationalHeart, 
Lung, and Blood Institute’s Percutaaeous Traosluminal Core- 
my AnghpMy Registry (18) reported that the chaoce of 
pmiprocedmal occlusion in patients with acxite -nary syn- 
dromewas6O%bi&erthaninpatieotswitbstabkangha 
pedork. iu addition, EUk et al. (5) found that coronary 
angbpky in patkots with recent myocardial ihrctioo in- 
creasedcostby17%.Anotberreasonfortbehigherrateof 
complications in the reuse center may have been the higher 
chauce of~traoma to the vascL Crossing protIle was higher 
with reused catheters bfxause they lose the lubrkated surface 
ooatingsanddonotwrapasweUasnewcatktets.Rensed 
catheters mytired more eat&e maniptda~ that new 
catheters, which may bate induced ,vx%-f intraiasclllar 
trauma (6). 
Tlie strong association of in-hospital cxnphtions with 
bospitalcostkweUdoamxnted.GhenetaL(19)cwtpered 
tJ~axtsforcom~otiooalang@hty,direchnalatberectomy 
~stentingin211patients.TbecostofsteatiogwaSsig0ili- 
cantlyhi&erthanconventionai 
athereuomybecaoseofthevpscularmm&gfterstent- 
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ing. The greater cost incurred was the result of longer hospital 
stays, more laboratory tests and more blood bank services. In 
the setting of catheter reuse, moderate savings could be 
wed if the complication rate5 were not significantly in- 
creased compared with a single-use strategy. 
Ballooa catheters. In our models, the different number of 
balloons in each of the strategies affected the potential cost 
savings. The number of balloons used per lesion in the “worst 
case” scenario was twice that of the single-use strategy. This 
finding may be partly explained by the higher failure rate of 
reused balloons in crossing lesions (10.2% vs. 3.3%) in the 
Canadiin study (6). In addition, the greater number of bal- 
loons used may reflect diierent dilation strategies in the 
single-use and reuse centers. Operators in the reuse centers 
used undersized balloon catheters first, increasing the balloon 
size as needed, because they believed that this strategy was 
safer and that the balloons were cheaper (ti). The total number 
of balloon catheters used to treat a lesion may not be signifi- 
cantly diierent between new and reused catheters (as assumed 
in the “best case” scenario). In fact, Rozenman et al. (20) 
reported from a center that routinely reused catheters that the 
average number of balloon catheters used per lesion was 1.3. 
This was similar to the average number of balloon catheters 
used per lesion in the single-use center of Plante’s study (6). 
However, in this study (20), balloon catheters were only reused 
once and the number of lesions treated for each patient was 
greater, making comparison between these two studies diffi- 
cult. 
The number of times a catheter could be reused may be 
related to the potential for savings. Although the Council for 
Health Technologies in Quebec (2) suggested that the incre- 
mental savings from catheters after three uses was minimal, we 
found that reuse up to five times was associated with substan- 
tial savings. For exampIe, in the “likely case” scenario, to afford 
savings, the cost of catheters would have to increase from $279 
to $402 per patient if catheters were reused twice instead of 
fie times (with only 80% of the catheters reusable). This 
increase represented an increased cost of approximately 44% 
for balloon catheters. 
However, balloon catheters made up only 7.4% of the total 
in-hospital cost. This was a relatively small proportion of the 
total, and therefore potential savings could be easily affected 
by the rates of expensive revascularization procedures. From 
the sensitivity analysis using the cost of catheters, it was clear 
that potential savings depended largely on the reuse strategies. 
In a strategy with high complication rates, potential savings 
would be unlikely. On the other hand, with low complication 
rates, the chance for potential savings increased. In addition, 
we have also shown that as the cost of catheters fell, so dii the 
likelihood that a reuse strategy would be associated with a 
reduction in cost. 
Pmeednre t&. Another important consideration in re- 
source utilization is procedure time, With the reuse strategy, 
procedure time was 13 min (20%) longer than with the 
single-use strategy (6) (Table l}, which was probably the result 
of diiferences in technique for dilation and increased technical 
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difficulty (i.e., increased crossing times and failure rates). 
Lengthening procedure time reduces the number of patients 
that can be treated and therefore increases cost. In addition, 
treatment of other patients may be delayed. Ellis et al. (5) 
estimated that a delay in treatment could increase cost by 6!% 
lo 86%. 
Prolonged procedure time was also associated with an 
increase in the event rates of death, myocardial infarction and 
subsequent need for revascularization after coronary angio- 
plasty or directional atherectomy after 6 months (21). In this 
Erst rxge-scale randomized trial alping an antagonist to platelet 
glycoprotein receptor IIb/IIIa, trlere was a 9% increase in these 
events for every 30 min of incre,lszd procedural time. 
Study limitations. Because the results of this study are 
based on theoretical models, there are several potential limi- 
tations. First, the clinical data were obtained from a nonran- 
domized study from two different centers in Canada. There 
were distinct differences in the clinical settings, medical treat- 
ment strategies, angioplasty practice patterns and operator 
experience between these two centers, which could have 
affxted the findings of the study. In addition, the CUrrent 
practice of using stents to treat threatened or abrupt vessel 
closure may reduce the need for urgent revascularization 
procedures, and possibly cost. More recently, the preliminary 
results of a prospective randomized study (22) suggested that 
reuse of coronary angioplasty catheters was not associated with 
increased rates of urgent revascularization in 1,033 procedures. 
A total of 753 (73%) procedures were randomized to reused 
catheters. The rates of crossing :he lesion were similar between 
patients receiving new and reused catheters. As the majority of 
the patients in this study had unstable ischemic syndromes, the 
rates for urgent bypass surgery were higher-5.7% for new 
catheters and 5.3% for reused catheters. Out-of-laboratory 
abrupt vessel closure was 0.7% and 1.2% for patients receiving 
new and reused catheters, respectively. Similarly, a study from 
an Israeli center that reused balloon catheters (20) showed that 
adverse complication rates were got prohibitive. 
Second, several assumptions were made in formulating the 
----Im.. models. These assumptions, such 3; :hi prVpLLIvII of ca:h;- 
ters that could be reused, number of balloons used and rates 
for urgent revascularization in the various case scenarios, 
would require a randomized trial for verification. Such a trial 
would require at least 7,700 patients in each of the two groups 
to detect a minimal cost difference of $500 per patient, based 
on the standard deviation of $11,031 with a power of 0.8 and (Y 
of 0.05. However, the three models and sensitivity analyses 
probably accurately reflect the spectrum of possible results of 
a prospectiye trial. 
Third, the long-term results of coronary angioplasty em- 
ploying reused catheters are unknown. If the resteoosis rate is 
higher with reused catheters, these patients may require repeat 
procedures, therefore increasing cost. 
Finally, we did not consider other devicks used for percu- 
taneous coronary intervention, such as intravascular ultra- 
sound, high speed rotational or diiectional athenxtomy and 
laser ablation, which are at least two to three times more 
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expensive than balloon catheters. These devices are finding 
their niches in intervendonal cardiology and their use is 
increasingly common. For example, intravascular ultrasound 
imaging is frequently used after ooronary stenrmg to ensure 
adequent strut expansion and apposition (U), and high speed 
rotational atherectomy is used for calcified lesions (24). In 
addition, several burrs of diierent sires may be used in a single 
patient, and balloon angioplasty is commonly used as an 
adjunct procedure. Therefore, if reuse of these devices could 
be shown to be safe and efficacious, potential for savings would 
be increased in both the absolute and relative (-20% of total 
cost) amounts (5). 
Conelusions. Our study was designed to evaluate the cost- 
effectiveness of reusing coronary angioplasty balloon catheters. 
We came to the conclusion that even a modest increase in 
complication rates associated with reused catheters would 
potentially negate any savings. These results suggest that a 
catheter reuse program should only be implemented if com- 
plication rates are no greater than those associated with new 
catheters. Of note, preliminary data from a recent randomized 
trial suggested that reuse of coronary angioplasty balloon 
catheters was not associated with an increase in complication 
rates. Although the maximal possible savings would be the cost 
of the new catheters reuse of percutaneous coronary interven- 
tional equipment may be extended to include rotablator burrs, 
intravascular ultrasound catheters and other expensive, cur- 
rently labeled “single-use only” products. 
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